"Dr. Giovannoni, you familiar with NurOwn for the treatment of ALS and MS? The data looks better for treating ALS and the reduction in NfL is very compelling, as in the reduction in the slope of the ALSFRS. Do you agree the data for NurOwn and ALS is sound?"